Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

SB-649868

Generic Name: SB-649868

Drug Type: Small Molecule

Chemical Formula: C_₂₆H_₂₄FN_₃O_₃S

CAS Number: 380899-24-1

Unique Ingredient Identifier: 1L1V1K2M4V

Overview

SB-649868 is under investigation in clinical trial NCT01030939 (Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers).

Background

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers.

Phase 1

Completed

Posted: 2011/02/18

Sponsor:GlaxoSmithKline

ID:NCT01299597

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Phase 1

Completed

Posted: 2009/12/14

Sponsor:GlaxoSmithKline

ID:NCT01030939

A Clinical Study to Evaluate the Pharmacokinetic Profile of SB-649868 in Elderly and Female Population

Phase 1

Withdrawn

Posted: 2007/09/26

Sponsor:GlaxoSmithKline

ID:NCT00534872

15-Day Repeated-Dose Study With SB-649868 And Its Interaction With CYP3A4 Isoenzyme In Healthy Male Subjects.

Phase 1

Completed

Posted: 2007/07/03

Sponsor:GlaxoSmithKline

ID:NCT00495729

Disturbed Sleep Model Study.

Phase 1

Completed

Posted: 2007/02/27

Sponsor:GlaxoSmithKline

ID:NCT00440323

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy